VAERS reports by lot

GSK Hepatitis A lot F4EL2: VAERS reports

21 VAERS reports list lot F4EL2 as a GSK Hepatitis A vaccine, received between 2018-12-30 and 2021-12-25. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1028%
General / Systemic (non-local)617%
Injection-site / Local reaction617%
Gastrointestinal411%
Dermatological (non-injection-site)411%
Psychiatric / Neuropsychiatric38%
Cardiac / Cardiovascular13%
Allergic / Anaphylactic13%
Musculoskeletal13%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Georgia4
Michigan3
Texas3
Virginia2
Kentucky1
Indiana1
New York1
Florida1
Oklahoma1
Massachusetts1
Connecticut1
California1

Reports by month received

MonthReportsBar
2018-121
2019-031
2019-044
2019-055
2019-061
2019-072
2019-081
2019-091
2019-101
2021-082
2021-122

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Hepatitis A lots (A–Z): EP47E · EP724 · F22EZ · F73DG · F7X23 · FB3A3

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.